Tubular Epithelia-Specific Deletion of MCP-1 Does Not Afford Protection Against Adriamycin-Induced Kidney Injury
International Journal of Molecular Sciences · 06.03.2026 · 27 (5) · 2432
DOI: 10.3390/ijms27052432 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.03.2026. Verfasst von Corry D Bondi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, PA 152671, USA. Hauptthemen laut MEDLINE: Chemokine CCL2, Doxorubicin, Kidney Tubules. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, BLRD VA.
Abstract (Originalsprache)
The increasing global burden of chronic kidney disease (CKD) magnifies an urgent need to find treatable targets. Monocyte chemoattractant protein-1 (MCP-1/CCL2) is a chemokine secreted by kidney tubular epithelia in response to a variety of stimuli. To better understand the effects of tubular MCP-1 in response to kidney injury, we generated tubular epithelia-specific MCP-1 knockout mice (KO; Pax8-Mcp-1fl/fl). We then exposed these mice and their control littermates to Adriamycin (Adr; 18 mg/kg, IV bolus). Thirty-two days after Adr injection, Mcp-1 transcript and protein levels were suppressed in the KO mice compared to their wild-type (WT) littermates. The KO mice exhibited no effect on survival, change in body weight, albuminuria, kidney function, glomerular or tubular injury, or tubulointerstitial fibrosis compared to WT. Overall, the results suggest that tubule-secreted MCP-1 is not necessary for progression of Adr-induced injury. These findings contribute to our understanding of the role of MCP-1 in kidney injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, PA 152671, USA.
- Kidney Medicine Section, Medical Service, VA Pittsburgh Healthcare System, Pittsburgh, PA 15212, USA.
ORCID-Profile: Roderick J Tan
Förderung
- NIDDK NIH HHS
- NIH HHS
- BLRD VA
- American Society of Nephrology Carl W. Gottschalk Research Scholar Grant
- Department of Veterans Affairs Merit Award
- National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases
- Pittsburgh Center for Kidney Research
- NIDDK
Zitieren
APA
Bondi, C. D., Hartman, H. L., Gilbert, J. L., Stewart, J. A., Clayton, D. R., & Tan, R. J. (2026). Tubular Epithelia-Specific Deletion of MCP-1 Does Not Afford Protection Against Adriamycin-Induced Kidney Injury. International Journal of Molecular Sciences, 27(5), 2432. https://doi.org/10.3390/ijms27052432
Vancouver
Bondi CD, Hartman HL, Gilbert JL, Stewart JA, Clayton DR, Tan RJ. Tubular Epithelia-Specific Deletion of MCP-1 Does Not Afford Protection Against Adriamycin-Induced Kidney Injury. International Journal of Molecular Sciences. 2026;27(5):2432. doi:10.3390/ijms27052432
BibTeX
@article{Bondi2026,
author = {Bondi, Corry D and Hartman, Hannah L and Gilbert, Josie L and Stewart, Joy A and Clayton, Dennis R and Tan, Roderick J},
title = {Tubular Epithelia-Specific Deletion of MCP-1 Does Not Afford Protection Against Adriamycin-Induced Kidney Injury},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {5},
pages = {2432},
doi = {10.3390/ijms27052432}
}
EUVIMED